Duke Cancer Institute

Last updated
Duke Cancer Institute
Duke Cancer Institute
Geography
Location Durham, North Carolina, United States
Coordinates 36°00′14″N78°56′20″W / 36.003767°N 78.938812°W / 36.003767; -78.938812 Coordinates: 36°00′14″N78°56′20″W / 36.003767°N 78.938812°W / 36.003767; -78.938812
Organization
Type Specialist
Affiliated university Duke University
Services
Speciality Oncology
History
Opened1971
Links
Website dukecancerinstitute.org
Lists Hospitals in North Carolina

The Duke Cancer Institute (DCI) is a National Cancer Institute-designated Comprehensive Cancer Center, research facility, and hospital. [1] Founded in 1971, the center is part of the Duke University School of Medicine and Duke University Health System located in Durham, North Carolina, United States. [2] [3]

Contents

The center specializes in the treatment and prevention of cancer and was ranked 41st in the U.S. News & World Report's 2021 list of top cancer hospitals. [4] More than 10,000 new cancer patients are seen at Duke each year. [5] The institutesinged the National Cancer Act of 1971 and became an NCI-designated cancer center in 1973. [6]

In November 2010, Victor Dzau, MD, chancellor of health affairs for Duke University, formally unveiled the Duke Cancer Institute, during the topping out ceremony for the new building. [7]

The DCI is a single entity—the first of its kind at Duke—that integrates and aligns patient care and basic and clinical research with the goals of improving patient outcomes, decreasing the burden of cancer and accelerating scientific progress. [8]

Michael B. Kastan, a cancer scientist and Director of the Comprehensive Cancer Center at St. Jude Children’s Research Hospital, was named as the first Executive Director of the Duke Cancer Institute in May 2011. [9] Eun-Sil Shelley Hwang became the institute's first female Chief of Breast Surgery. [10]

On February 27, 2012, the Duke Cancer Institute opened the Duke Cancer Center, a new seven-floor building devoted exclusively to cancer care. [11]

Clinical milestones

In June 2018, the institute published a study in The New England Journal of Medicine showing how a genetically genetically modified poliovirus therapy improved long-term survival for patients with recurrent glioblastoma. [12] [13] [14] Patients shoed a three-year survival rate of 21 percent. [15]

Related Research Articles

<span class="mw-page-title-main">Glioblastoma</span> Aggressive type of brain cancer

Glioblastoma, previously known as glioblastoma multiforme (GBM), is one of the most aggressive types of cancer that begin within the brain. Initially, signs and symptoms of glioblastoma are nonspecific. They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke. Symptoms often worsen rapidly and may progress to unconsciousness.

<span class="mw-page-title-main">Casa Sollievo della Sofferenza</span> Research hospital in Italy

Casa Sollievo della Sofferenza is a private scientific research hospital in San Giovanni Rotondo, Italy, founded by Saint Pio of Pietrelcina, and administered by Vatican City. Inaugurated on 5 May 1956, the hospital has adopted modern technologies and is often considered as one of the most efficient scientific research hospitals in Europe. The building is situated at the highest part of the town, on the top of the hill, giving the location an identity of a hospital-town. Casa Sollievo della Sofferenza has two major activity wings. One of which is an internationally regarded hospital for the relief of suffering and the other is a state-of-the-art scientific research centre which had received the status of a Scientific Hospitalization and Treatment Institute (IRCCS), an institute of national interest, by the decree of Italian Ministry of Health in 1991. The research centre is also home to the Genomic and Genetic Disorders Biobank which is part of the Telethon Network of Genetic Biobanks and conducts basic and pre-clinical research and clinical trials in collaboration with pharmaceutical companies. It is first in the world to run non-profit clinical trials. The hospital has established Institute for Stem-cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT) that will be the first factory of GMP neural stem cells in Europe for producing bio-drugs and cell-drugs. ISBReMIT has a dedicated area for the start-ups and spin-offs in biotechnology. Casa Sollievo della Sofferenza also houses a large out-patient clinic, a hospital-school for the children suffering from cancer and other genetic disorders, a reception centre which is a hotel complex, and a social-assistance residence for elderly. Casa Sollievo della Sofferenza also owns two agricultural companies-Masseria Calderoso and Posta La Via. It also hosts one spiritual centre, prayer group and a church. In front of Casa Sollievo della Sofferenza there is Sanctuary of Saint Pio of Pietrelcina, named after the founder of this hospital and research centre.

Dana–Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana–Farber is the founding member of Dana–Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.

<span class="mw-page-title-main">H. Lee Moffitt Cancer Center & Research Institute</span> Hospital in Florida, United States

Houston Lee Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986 on the University of South Florida's campus. Moffitt is one of two National Cancer Institute-designated Comprehensive Cancer Centers based in Florida. In 2021, U.S. News & World Report ranked Moffitt Cancer Center as a top 30 cancer hospital in the United States.

<span class="mw-page-title-main">Ductal carcinoma in situ</span> Medical condition

Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, is a pre-cancerous or non-invasive cancerous lesion of the breast. DCIS is classified as Stage 0. It rarely produces symptoms or a breast lump one can feel, typically being detected through screening mammography. It has been diagnosed in a significant percentage of men.

<span class="mw-page-title-main">City of Hope National Medical Center</span> U.S. clinical research center and hospital

City of Hope is a private, not-for-profit clinical research center, hospital and graduate school located in Duarte, California, United States. The center's main campus resides on 110 acres (45 ha) of land adjacent to the boundaries of Duarte and Irwindale, with a network of clinical practice locations throughout Southern California, satellite offices in Monrovia and Irwindale, and regional fundraising offices throughout the United States.

Duke University Hospital is a 957-bed acute care facility and an academic tertiary care facility located in Durham, North Carolina. Established in 1930, it is the flagship teaching hospital for the Duke University Health System, a network of physicians and hospitals serving Durham County and Wake County, North Carolina, and surrounding areas, as well as one of three Level I referral centers for the Research Triangle of North Carolina. It is affiliated with the Duke University School of Medicine.

<span class="mw-page-title-main">Karmanos Cancer Institute</span> Cancer research and provider network

The Barbara Ann Karmanos Cancer Institute, headquartered in Detroit, is the largest cancer research and provider network in Michigan and has 16 treatment locations. It is one of 51 National Cancer Institute-designated comprehensive cancer treatment and research centers in the United States. Affiliated with the Wayne State University School of Medicine, the institute has 1,000 staff members, including 300 doctors, and 100 researchers. The staff treats approximately 12,000 patients each year and operates with a budget of $260 million.

Wafik El-Deiry is an American physician and cancer researcher who is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Brown University, Director of the Cancer Center at Brown University, and the Director of the Joint Program in Cancer Biology at Brown University and its affiliated hospitals. He was previously deputy director of Translational Research at Fox Chase Cancer Center, where he was also co-Leader of the Molecular Therapeutics Program.

Alternating electric field therapy, sometimes called tumor treating fields (TTFields), is a type of electromagnetic field therapy using low-intensity, intermediate frequency electrical fields to treat cancer. A TTField-generating device manufactured by the Israeli company Novocure is approved in the United States and Europe for the treatment of newly diagnosed and recurrent glioblastoma multiforme (GBM), and is undergoing clinical trials for several other tumor types. Despite earning regulatory approval, the efficacy of this technology remains controversial among medical experts.

The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is a cancer treatment, research and education institution with six locations in the St. Louis area. Siteman is the only cancer center in Missouri and within 240 miles of St. Louis to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Siteman is also the only area member of the National Comprehensive Cancer Network, a nonprofit alliance of 32 cancer centers dedicated to improving the quality and effectiveness of cancer care.

Good Samaritan University Hospital is a 537-bed non-profit teaching hospital on Long Island located in West Islip, New York. The hospital contains 100 nursing home beds as well as operates an adult and pediatric Level II trauma center. Good Samaritan University Hospital opened in May 1959, and has expanded several times since opening. It has been Magnet-designed for its quality nursing since 2006, and is a member of Catholic Health. The hospital is also a major regional clinical campus for clinical clerkships and postgraduate medical training affiliated with the New York Institute of Technology College of Osteopathic Medicine, one of the largest medical schools in the United States.

Gibbs Cancer Center & Research Institute is a cancer treatment and research facility in Upstate South Carolina. Gibbs Cancer Center is associated with the NCI Community Cancer Centers Program and the Medical University of South Carolina. Gibbs headquarters is located on the campus of the Spartanburg Medical Center (SRMC) in Spartanburg, SC.

Dr. Matthias Gromeier is a Professor in the Department of Neurosurgery at Duke University Medical Center, who has developed a way to re-engineer a poliovirus to inspire the human immune system to kill cancer cells in a specific set of cancers. The re-engineered virus, called PVSRIPO, cannot replicate itself in normal cells, but can replicate itself in cancer cells that have an overabundance of the protein marker that the poliovirus targets.

PVSRIPO, or PVS-RIPO, is the name of a modified polio virus that has recently shown promise for treating cancer. It is the focus of clinical trials being conducted at Duke University.

John Howard Sampson, M.D., Ph.D, M.B.A, M.H.S.c, is the former chief of the department of neurosurgery at Duke University where he serves as a professor of surgery, biomedical engineering, immunology, and pathology.

<span class="mw-page-title-main">Seattle Cancer Care Alliance</span> Cancer treatment and research center in Seattle, U.S.

Seattle Cancer Care Alliance (SCCA) is a cancer treatment and research center in Seattle, Washington. Established in 1998, this nonprofit provides clinical oncology care for patients treated at its three partner organizations: Fred Hutchinson Cancer Research Center, Seattle Children's and UW Medicine. Together, these four institutions form the Fred Hutch/University of Washington Cancer Consortium.

Winship Cancer Institute of Emory University is a nonprofit cancer research and patient care center based in Atlanta, Georgia. Winship Cancer Institute is the only National Cancer Institute-designated Comprehensive Cancer Center in Georgia.

Carolyn Kaelin was an American cancer surgeon. She worked at the Dana–Farber Cancer Institute and founded the Comprehensive Breast Health Center at Brigham and Women’s Hospital in 1995.

University of Virginia Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center affiliated with the University of Virginia School of Medicine and the UVA Health System.

References

  1. "Duke Comprehensive Cancer Center". cancer.gov. National Cancer Institute. Archived from the original on 2007-08-20. Retrieved 2009-07-30.
  2. "Cancer Services". Duke University Health System. Retrieved 2009-07-30.
  3. Thomas, Patrick (2022-04-14). "Cancer survivor highlight of Duke Cancer Institute 50th anniversary". spectrumlocalnews.com. Retrieved 2023-02-13.
  4. "Best Cancer Hospitals". U.S. News & World Report. Retrieved 2021-05-25.
  5. "About - Duke Cancer Institute". Duke Cancer Institute. Retrieved 2021-05-25.
  6. "50 years of Duke cancer care". The Cancer Letter. 2022-07-08. Retrieved 2023-02-13.
  7. "Public gets first official glimpse at Duke Cancer Center at topping-out ceremony". Herald Sun. Archived from the original on 2011-09-27. Retrieved 2010-11-24.
  8. "Cancer Centers Program". National Cancer Institute. Archived from the original on 2007-08-20. Retrieved 2011-07-05.
  9. "Kastan to Lead Duke Cancer Institute". Duke Chronicle. Retrieved 2011-07-05.
  10. "First female chief of breast surgery at Duke named one of Time's 'Most Influential Americans'". apnews.com. March 26, 2018. Retrieved March 29, 2020.
  11. "OPEN HOUSE FOR NEW DUKE CANCER CENTER". today.duke.edu. February 14, 2012. Retrieved March 29, 2020.
  12. "Brain Cancer Gets the Polio Treatment". Genetic Engineering and Biotechnology News. 2018-06-26. Retrieved 2023-02-13.
  13. Desjardins, Annick; Matthias, Gromeier; Herndon, James E. (2018-07-12). "Recurrent Glioblastoma Treated with Recombinant Poliovirus". The New England Journal of Medicine.
  14. Cohut, Maria (2020-02-01). "How a modified poliovirus may help fight brain cancer". www.medicalnewstoday.com. Retrieved 2023-02-13.
  15. "Poliovirus Extends Survival for Patients With Glioblastoma in Early-Phase Trial". Cure Today. Retrieved 2023-02-13.